Access cutting-edge cidp treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access cidp specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cidp treatment provided free
The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) who initially respond to nipocalimab in Stage A.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this cidp clinical trial in New York, NY
If you're searching for cidp treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cidp specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.